Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Nonlinear relationship of red blood cell indices (MCH, MCHC, and MCV) with all-cause and cardiovascular mortality: A cohort study in U.S. adults.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Background: In recent years, increasing attention has been focused on the impact of red blood cell indices (RCIs) on disease prognosis. We aimed to investigate the association of mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and mean corpuscular volume (MCV) with mortality.
      Methods: The study used cohort data from U.S. adults who participated in the 1999-2008 National Health and Nutrition Examination Survey. All-cause mortality was the primary outcome during follow-up, with secondary cardiovascular mortality outcomes. COX regression was applied to analyze the connection between RCIs and mortality. We adopted three models to minimize potential bias. Smooth-fit curves and threshold effect analyses were utilized to observe the dose-response relationship between RCIs and all-cause and cardiovascular mortality. In addition, we performed sensitivity analyses.
      Results: 21,203 individuals were enrolled in our research. During an average 166.2 ± 54.4 months follow-up, 24.4% of the population died. Curve fitting indicated a U-shaped relationship between MCV and MCH with all-cause mortality, and the relationship of MCHC to all-cause mortality is L-shaped. We identified inflection points in the relationship between MCV, MCH, and MCHC and all-cause mortality as 88.56732 fl, 30.22054 pg, 34.34624 g/dl (MCV <88.56732 fl, adjusted HR 0.99, 95 CI% 0.97-1.00; MCV >88.56732 fl, adjusted HR 1.05, 95 CI% 1.04-1.06. MCH <30.22054 pg, adjusted HR 0.95, 95 CI% 0.92-0.98; MCH >30.22054 pg, adjusted HR 1.08, 95 CI% 1.04-1.12. MCHC <34.34624 g/dl, adjusted HR 0.88, 95 CI% 0.83-0.93). Besides, the MCV curve was U-shaped in cardiovascular mortality (MCV <88.56732 fl, adjusted HR 0.97, 95 CI% 0.94-1.00; MCV >88.56732 fl, adjusted HR 1.04, 95 CI% 1.01-1.06).
      Conclusion: This cohort study demonstrated that RCIs (MCH, MCHC, and MCV) were correlated with mortality in the general population. Three RCIs were nonlinearly correlated with all-cause mortality. In addition, there were nonlinear relationships between MCH and MCV and cardiovascular mortality.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Sci Rep. 2021 Sep 24;11(1):19052. (PMID: 34561491)
      Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1205-16. (PMID: 16910768)
      Int J Mol Sci. 2021 May 29;22(11):. (PMID: 34072544)
      Prev Med. 2009 Aug;49(1):45-7. (PMID: 19409924)
      Biorheology. 1990;27(1):21-37. (PMID: 2361163)
      Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221121286. (PMID: 36045634)
      Vital Health Stat 2. 2013 Sep;(161):1-24. (PMID: 25090154)
      Am J Kidney Dis. 2005 Jan;45(1):127-35. (PMID: 15696452)
      J Am Soc Nephrol. 2006 Feb;17(2):537-45. (PMID: 16382015)
      Clin Med Res. 2006 Sep;4(3):236-41. (PMID: 16988104)
      Intern Emerg Med. 2023 Nov;18(8):2301-2310. (PMID: 37740867)
      Clin Hemorheol Microcirc. 2016;62(1):45-54. (PMID: 26410854)
      Kardiol Pol. 2016;74(7):657-64. (PMID: 26779853)
      Congest Heart Fail. 2013 Jul-Aug;19(4):180-5. (PMID: 23279093)
      Clin Res Cardiol. 2020 May;109(5):616-627. (PMID: 31535171)
      Clin J Am Soc Nephrol. 2017 Feb 7;12(2):237-244. (PMID: 28143866)
      Aging Clin Exp Res. 2018 May;30(5):517-526. (PMID: 28664457)
      J Clin Lab Anal. 2017 Sep;31(5):. (PMID: 27735087)
      Age Ageing. 1996 Jul;25(4):310-2. (PMID: 8831877)
      Dis Markers. 2022 Nov 3;2022:2193343. (PMID: 36393972)
      J Gerontol A Biol Sci Med Sci. 2010 Mar;65(3):258-65. (PMID: 19880817)
      PLoS One. 2016 Dec 9;11(12):e0167000. (PMID: 27936006)
      Dis Markers. 2020 Jul 16;2020:8874361. (PMID: 32724484)
      Stroke. 2023 Apr;54(4):1021-1029. (PMID: 36779340)
      Medicine (Baltimore). 1989 Sep;68(5):309-20. (PMID: 2677598)
      Am J Clin Pathol. 1983 Sep;80(3):322-6. (PMID: 6881096)
      Eur Heart J. 1987 Sep;8 Suppl F:23-6. (PMID: 3665963)
      J Nephrol. 2022 Mar;35(2):535-544. (PMID: 34213761)
      BMJ. 2021 Apr 14;373:n604. (PMID: 33853828)
      Am J Hematol. 2013 Nov;88(11):E245-9. (PMID: 23828763)
      Mymensingh Med J. 2013 Apr;22(2):370-6. (PMID: 23715364)
      Int J Cardiol. 2017 Apr 1;232:105-110. (PMID: 28117138)
      Scand J Clin Lab Invest. 2000 Feb;60(1):9-18. (PMID: 10757449)
      Int J Lab Hematol. 2014 Feb;36(1):98-104. (PMID: 23941574)
      Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103867. (PMID: 35642292)
      J Transl Med. 2017 Oct 13;15(1):208. (PMID: 29029617)
      Clin Chim Acta. 2022 Feb 15;527:38-46. (PMID: 34979101)
      PLoS One. 2022 Mar 24;17(3):e0265758. (PMID: 35324947)
      J Am Heart Assoc. 2018 Jan 29;7(3):. (PMID: 29378732)
      Am J Hematol. 2013 Jan;88(1):5-9. (PMID: 23044913)
      Am Fam Physician. 2009 Feb 1;79(3):203-8. (PMID: 19202968)
    • الموضوع:
      Date Created: 20240802 Date Completed: 20240802 Latest Revision: 20240804
    • الموضوع:
      20240804
    • الرقم المعرف:
      PMC11296621
    • الرقم المعرف:
      10.1371/journal.pone.0307609
    • الرقم المعرف:
      39093828